Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05597800
Title Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome (LUNGVIR)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Universita di Verona
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Centro Ricerche Cliniche Verona Veneto/Verona 37134 Italy Details
*Shaded cells indicate that there was no data available from for the field